Holen Sie sich die Stockscreener-App
2.85
1.72%
-0.06
Schlusskurs vom Vortag:
$2.91
Offen:
$2.94
24-Stunden-Volumen:
110.93K
Relative Volume:
0.08
Marktkapitalisierung:
$100.23M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-9.32M
KGV:
-0.2242
EPS:
-12.7107
Netto-Cashflow:
$-7.30M
1W Leistung:
-15.38%
1M Leistung:
+10.00%
6M Leistung:
+62.50%
1J Leistung:
+31.80%
1-Tages-Spanne:
$2.85
$2.98
1-Wochen-Bereich:
$2.85
$3.44
52-Wochen-Spanne:
$0.952
$9.08
Tharimmune Inc Stock (THAR) Company Profile
Firmenname
Tharimmune Inc
Sektor
Branche
Telefon
302-743-2995
Adresse
1200 ROUTE 22 EAST, BRIDGEWATER
Vergleichen Sie THAR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
THAR
Tharimmune Inc
|
2.86 | 101.98M | 0 | -9.32M | -7.30M | -12.71 |
|
VRTX
Vertex Pharmaceuticals Inc
|
471.19 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
810.84 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
408.64 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
815.91 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
176.19 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Tharimmune Inc Aktie (THAR) Neueste Nachrichten
Is Tharimmune Inc. stock a safe buy before earningsQuarterly Profit Report & Verified Momentum Stock Alerts - ulpravda.ru
What analyst consensus says on Tharimmune Inc. stockTrade Entry Report & Safe Entry Momentum Stock Tips - ulpravda.ru
Published on: 2026-01-09 04:07:29 - ulpravda.ru
Is Tharimmune Inc. stock attractive for income investorsJuly 2025 Earnings & AI Optimized Trading Strategy Guides - ulpravda.ru
Will Tharimmune Inc. stock reach Wall Street targetsJuly 2025 Update & Reliable Entry Point Trade Alerts - ulpravda.ru
Breakout Zone: Is Tharimmune Inc stock attractive for income investorsRecession Risk & Safe Capital Growth Trade Ideas - moha.gov.vn
Tharimmune Announces Key Leadership Appointments Including James Gordon Liddy Joining Board of Directors - Burlington Free Press
What technical signals suggest for Tharimmune Inc. stockJuly 2025 Chart Watch & Safe Entry Momentum Stock Tips - Улправда
Can Tharimmune Inc. stock hit record highs again2025 Stock Rankings & AI Forecast Swing Trade Picks - Улправда
Will Tharimmune Inc. stock benefit from AI adoptionWeekly Trend Report & High Conviction Trade Alerts - DonanımHaber
THAR SEC FilingsTharimmune Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Tharimmune (NASDAQ:THAR) Stock Price Down 5.9%What's Next? - MarketBeat
Is Tharimmune Inc. stock attractive for ETFs2025 Fundamental Recap & Weekly Return Optimization Alerts - DonanımHaber
How Tharimmune Inc. stock performs in rising dollar environmentJuly 2025 Opening Moves & Community Verified Trade Alerts - DonanımHaber
Sentiment Recap: Can Tharimmune Inc. stock weather global recession2025 AllTime Highs & Capital Protection Trade Alerts - Улправда
Tharimmune, Inc. Statement on DTCC's Initiative to Tokenize U.S. Treasury Securities on the Canton Network - marketscreener.com
DTCC move to tokenize $30T in Treasuries—and why one biotech cares - Stock Titan
DTCC partners with Digital Asset to tokenize US Treasury securities - Investing.com
Tharimmune (THAR) outlines 176,934,358-share PIPE resale and Canton Coin strategy - Stock Titan
Tharimmune (NASDAQ: THAR) seeks approval for new directors, warrants and 7M-share equity plan boost - Stock Titan
Tharimmune appoints Jacob Asbury as new CFO - MSN
Tharimmune Appoints Jacob Asbury as Chief Financial Officer - citybiz
Tharimmune Appoints Jacob Asbury as New CFO - TipRanks
Tharimmune, Inc. Appoints New Chief Financial Officer - TradingView — Track All Markets
Tharimmune (NASDAQ: THAR) names Jacob Asbury CFO with new employment agreement - Stock Titan
Tharimmune appoints Jacob Asbury as chief financial officer - Investing.com
Tharimmune (NASDAQ: THAR) appoints ex‑Clear Street CFO Asbury to guide Canton Coin treasury build‑out - Stock Titan
Why Tharimmune Inc. stock remains a top recommendation2025 Market WrapUp & Free Real-Time Market Sentiment Alerts - Newser
How buybacks impact Tharimmune Inc. stock value2025 EndofYear Setup & Daily Risk Controlled Trade Plans - Newser
Tharimmune (NASDAQ: THAR) details agent change in $64,910,161 stock plan - Stock Titan
How Tharimmune Inc. stock reacts to Fed rate cutsPortfolio Gains Report & Consistent Income Trade Ideas - Newser
Tharimmune Appoints Renowned Counter-Terrorism and Critical Infrastructure Expert James Gordon Liddy (CDR US Navy SEAL (Ret)) as Key Strategic Advisor Against Weaponized Fentanyl and Other High-Potency Opioids Following Positive FDA Feedback - The Holland Sentinel
Will Tharimmune Inc. stock benefit from infrastructure spendingInsider Buying & Technical Entry and Exit Tips - Newser
Is Tharimmune Inc. stock attractive for growth ETFsEarnings Recap Summary & High Return Stock Watch Alerts - Newser
Tharimmune (THAR) Stock Analysis Report | Financials & Insights - Benzinga
Can Tharimmune Inc. stock weather global recessionMarket Trend Report & AI Enhanced Trade Execution Alerts - BỘ NỘI VỤ
Reviewing Tharimmune (NASDAQ:THAR) and Ventyx Biosciences (NASDAQ:VTYX) - Defense World
‘We refused to do an ICO’: The truth behind Canton’s tokenomics - TradingView — Track All Markets
Tharimmune Raises $545 Million in Private Placement to Acquire Canton Coin and Expand Blockchain Adoption - Global Legal Chronicle
What drives Tharimmune Inc stock priceSmall Cap Stock Opportunities & Build Capital Safely - earlytimes.in
Tharimmune Shares Jump After FDA Signals Support for TH104 Modeling Plan - MSN
Crypto Company Creates Bizarre Drug - Futurism
Tharimmune Stock Plummets -46% With 9-Day Losing Streak - Trefis
Using Bollinger Bands to evaluate Tharimmune Inc.Gap Up & Expert Curated Trade Setups - newser.com
Will Tharimmune Inc. stock benefit from sector rotationPortfolio Performance Report & Free Accurate Trade Setup Notifications - newser.com
Why analysts upgrade Tharimmune Inc. stockJuly 2025 Selloffs & Free Real-Time Volume Trigger Notifications - newser.com
How resilient is Tharimmune Inc. stock in market downturnsWatch List & Trade Opportunity Analysis Reports - newser.com
Is Tharimmune Inc. stock a buy for dividend growthTrade Exit Summary & Stepwise Swing Trade Plans - newser.com
What insider trading reveals about Tharimmune Inc. stock2025 Momentum Check & Safe Capital Growth Tips - newser.com
Is Tharimmune Inc. stock attractive for retirement portfoliosWeekly Gains Report & Capital Efficiency Focused Strategies - newser.com
Will Tharimmune Inc. stock deliver long term returnsInsider Selling & Verified Momentum Stock Alerts - newser.com
Finanzdaten der Tharimmune Inc-Aktie (THAR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):